Ironwood Pharmaceuticals, Inc. , a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, announced today that the ...
Cash position of €17.2m as of December 31, 2025Progresses achieved with our flagship projects in 2025:Chinese partner Tonghua Dongbao completed BioChaperone® Lispro Phase 3 program with positive ...
In a new study exploring stigma associated with the use of GLP-1 drugs for weight loss, women who lost weight using GLP-1 ...
Amazon is launching a new GLP-1 program through One Medical and Amazon Pharmacy to streamline access to popular weight-loss ...
The company's new GLP-1 program will offer both oral and injectable medications ...
Amazon One Medical has launched a GLP-1 management program that integrates primary care, pharmacy services and virtual care ...
On Tuesday, Amazon unveiled a new GLP-1 management program aimed at simplifying how patients access, and stay on, high-demand ...
The new program will combine One Medical’s primary care services with Amazon Pharmacy’s access to GLP-1 medications, ...
People on GLP-1s may struggle to get enough protein, fiber, and other nutrients. Can frozen dinners labeled ‘GLP-1 Friendly’ ...
An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid ...
An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid ...
Everyday Health on MSN
Oral GLP-1s vs. injectables: Which is right for you?
Although GLP-1 pills and injections work similarly for weight loss management for people with obesity, they have different administration schedules and costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results